Progression of Airway Obstruction in Childhood Asthma
Progression of Airway Obstruction in Childhood Asthma
批准号:
7529073
负责人:
Stanley J Szefler
金额:
$23.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2009-06-30
关键词:
AddressAdolescenceAdolescentAirAirway ResistanceAsthmaBiological MarkersBloodBronchodilator AgentsCaringCharacteristicsChildChildhoodChildhood AsthmaComplexDataDensitometryDevelopmentElastasesEndopeptidasesEnrollmentEosinophil-Derived NeurotoxinExhalationFrequenciesGelatinase BGuidelinesHospitalizationImageInflammationLeadLungMeasurementMeasuresMethodsMonitorMorbidity - disease rateNational Health and Nutrition Examination SurveyObstructionOralOutcomePancreatic ElastaseParticipantPatternPeptide HydrolasesPhenotypePhysiologicalPhysiologyPlasmaPopulation ProgramsPopulations at RiskProteinsProteolysisPublic HealthRandomizedRefractoryReportingResearchResearch DesignRespiratory physiologySchool-Age PopulationSecondary toSputumSteroid therapySteroidsStructureThickTimeTissue Inhibitor of Metalloproteinase-1UrineVisitWorkairway inflammationairway obstructionbasecohortearly childhoodfallsfollow-upimprovedinsightpreventprogramspulmonary functionresponseurinaryyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The course of persistent asthma in childhood is highly variable and incompletely understood. The NHLBI Childhood Asthma Management Program (CAMP) and CAMP Continuation Studies (CAMPCS) afford a unique opportunity to evaluate continuing asthma progression in over 1,000 participants undergoing observation from early childhood into early adulthood. The ongoing CAMPCS will provide a total 18 years observation for each participant. After the first 10 years of follow-up, approximately 1/3 of the CAMP population had significant airway obstruction. We identified two groups with lung function patterns resulting in significant airway obstruction and high asthma morbidity with increased frequency of urgent care visits and hospitalizations: (1) abnormal obstruction in early childhood and remaining abnormal (Persistent Obstruction) and (2) initially normal pulmonary function progressing to significant obstruction over time (Late Obstruction). These two groups were compared to two other groups with normal pulmonary function and favorable long-term outcomes: (1) initially abnormal and improving over time (Late Normal) and (2) normal throughout follow-up (Persistent Normal). The patterns of Persistent and Late Obstruction leading to significant obstruction are an intermediate phenotype of airway obstruction and continue to evolve. Both patterns are associated with airway proteinase/anti-proteinase imbalance, structural lung characteristics and poor response to oral steroid therapy. However, the group with Late Obstruction is distinguished by increased airway wall thickness, hyperinflation, urinary eosinophilic protein X, and plasma TGF¿ with decreased elastase complex, suggesting ongoing inflammation and compromised airway protective mechanisms. To explore the mechanisms of significant airway obstruction related to these developing patterns including ongoing decline in pulmonary function in this CAMP cohort, we will study biomarkers in induced sputum, urine, blood and exhaled air, indicators of steroid sensitivity, pulmonary physiology and imaging. Ongoing characterization of these four distinct patterns of pulmonary function during continued follow-up of this unique CAMP cohort will inform current and continued asthma progression as well as provide a set of characteristics useful in identifying a younger population at risk for asthma progression. Furthermore, these studies will generate hypothesis-driven research that will lead to the discovery of new strategies to manage progression in the CAMP cohort. They will also provide insight into methods to conduct studies to define mechanisms and formulate strategies to monitor efficacy in studies designed to prevent asthma progression in early childhood.
PUBLIC HEALTH RELEVANCE: Distinct patterns of loss in pulmonary function were identified in children with mild to moderate asthma participating in a 10-year observation period during the NHLBI Childhood Asthma Management Program. This loss in pulmonary function is likely related to ongoing inflammation unresponsive to current therapy. This study will measure indicators of airway inflammation which are associated with structural and physiologic changes in the lung and provide insight into mechanisms of asthma progression in adolescence and early adulthood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
-
批准号:10219823
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2017
-
负责人:Stanley J Szefler
-
依托单位:
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
-
批准号:9750796
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2017
-
负责人:Stanley J Szefler
-
依托单位:
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
-
批准号:9406584
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2017
-
负责人:Stanley J Szefler
-
依托单位:
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
-
批准号:10454973
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2017
-
负责人:Stanley J Szefler
-
依托单位:
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)
-
批准号:8691988
-
项目类别:
-
资助金额:$69.18万
-
财政年份:2009
-
负责人:Stanley J Szefler
-
依托单位:
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)
-
批准号:8882515
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2009
-
负责人:Stanley J Szefler
-
依托单位:
CAMP CONTINUATION STUDY/PHASE 2 (CAMPCS/2) PROTOCOL
-
批准号:7719390
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2008
-
负责人:Stanley J Szefler
-
依托单位:
TREATING CHILDREN TO PREVENT EXACERBATIONS OF ASTHMA (TREXA)
-
批准号:7719409
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2008
-
负责人:Stanley J Szefler
-
依托单位:
Progression of Airway Obstruction in Childhood Asthma
-
批准号:7672230
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2008
-
负责人:Stanley J Szefler
-
依托单位:
BEST ADD-ON THERAPY GIVING EFFECTIVE RESPONSES (BADGER)
-
批准号:7719408
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2008
-
负责人:Stanley J Szefler
-
依托单位:
CAMP CONTINUATION STUDY/PHASE 2 (CAMPCS/2) PROTOCOL
-
批准号:7604346
-
项目类别:
-
资助金额:$7.24万
-
财政年份:2007
-
负责人:Stanley J Szefler
-
依托单位:
MARS
-
批准号:7604360
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2007
-
负责人:Stanley J Szefler
-
依托单位:
CAMP CONTINUATION STUDY/PHASE 2 (CAMPCS/2) PROTOCOL
-
批准号:7377750
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2006
-
负责人:Stanley J Szefler
-
依托单位:
PREVENTION OF EARLY ASTHMA IN KIDS (PEAK)
-
批准号:7377737
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2006
-
负责人:Stanley J Szefler
-
依托单位:
ACUTE INTERVENTION MANAGEMENT STRATEGIES (AIMS)
-
批准号:7377747
-
项目类别:
-
资助金额:$4.61万
-
财政年份:2006
-
负责人:Stanley J Szefler
-
依托单位:
CAMP CONTINUATION STUDY/PHASE 2 (CAMPCS/2) PROTOCOL
-
批准号:7200514
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2005
-
负责人:Stanley J Szefler
-
依托单位:
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY
-
批准号:7200489
-
项目类别:
-
资助金额:$2.97万
-
财政年份:2005
-
负责人:Stanley J Szefler
-
依托单位:
PREVENTION OF EARLY ASTHMA IN KIDS (PEAK)
-
批准号:7200497
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2005
-
负责人:Stanley J Szefler
-
依托单位:
ACUTE INTERVENTION MANAGEMENT STRATEGIES (AIMS)
-
批准号:7200511
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2005
-
负责人:Stanley J Szefler
-
依托单位:
PEDIATRIC ASTHMA CONTROLLER TRIAL (PACT)
-
批准号:7200501
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2005
-
负责人:Stanley J Szefler
-
依托单位:
海外基金